Literature DB >> 8287984

Conjunctival autografting in the surgical management of pterygium.

P Riordan-Eva1, I Kielhorn, L A Ficker, A D Steele, C M Kirkness.   

Abstract

In a retrospective survey of 117 operations for primary or recurrent pterygium, conjunctival autografting was compared with both excision without conjunctival closure ('bare sclera excision') and excision with complete conjunctival closure. The probability of corneal recurrence at 36 months after surgery was determined by survival curve analysis. In previously unoperated cases conjunctival autografting (n = 15) resulted in a 14% probability of recurrence, compared with 70% for bare sclera excision (n = 50) and 69% for excision with complete conjunctival closure (n = 20). In previously operated cases conjunctival autografting (n = 17) resulted in a 7% probability of recurrence, compared with 82% for bare sclera excision (n = 15). Hazard ratio analysis confirmed the statistical significance of these results at the 95% confidence level. Conjunctival autografting was more likely to produce an improvement in visual acuity than other forms of surgery.

Mesh:

Year:  1993        PMID: 8287984     DOI: 10.1038/eye.1993.146

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium.

Authors:  S E Ti; S P Chee; K B Dear; D T Tan
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

2.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

3.  Comparison of mitomycin C and limbal-conjunctival autograft in the prevention of pterygial recurrence in Turkish patients: A one-year, randomized, assessor-masked, controlled trial.

Authors:  Seyhmus Ari; Ihsan Caca; Zennure Özdemir Yildiz; Yildirim Bayezit Sakalar; Eyüp Dogan
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

4.  Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium.

Authors:  J C Sánchez-Thorin; G Rocha; J B Yelin
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

5.  Intra-lesional 5 fluorouracil for the management of recurrent pterygium.

Authors:  D G Said; L A Faraj; M S Elalfy; A Yeung; A Miri; U Fares; A M Otri; I Rahman; S Maharajan; H S Dua
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

6.  Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon.

Authors:  J Shimazaki; N Shinozaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

7.  Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.

Authors:  Takashi Ono; Yosai Mori; Ryohei Nejima; Tadatoshi Tokunaga; Kazunori Miyata; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-26       Impact factor: 3.117

8.  Comparison of autologous fibrin glue versus nylon sutures for securing conjunctival autografting in pterygium surgery.

Authors:  Daryoush Hamidi Alamdari; Mohamad-Reza Sedaghat; Reza Alizadeh; Siamak Zarei-Ghanavati; Hashem Naseri; Fatemeh Sharifi
Journal:  Int Ophthalmol       Date:  2017-06-17       Impact factor: 2.031

9.  Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision.

Authors:  P Luanratanakorn; T Ratanapakorn; O Suwan-Apichon; R S Chuck
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

10.  Removal of Tenon fortified by conjunctival-limbal autograft in treatment of pterygium.

Authors:  Suleyman Ciftci; Eyup Dogan; Umut Dag; Leyla Ciftci
Journal:  Int Ophthalmol       Date:  2016-09-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.